Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection — Stella

Home/Chronic Subdural Hematoma/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Subdural Hematoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Cooper University Health Care, Camden, New Jersey

Key details

Phase

Early testing / Safety & dosing

Sponsor

The Cooper Health System

Collaborators

Society of Vascular and Interventional Neurology

Enrollment target

~140 participants

Started

June 2024

Primary completion

June 2028

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Last updated July 2025